Toronto Dominion Bank
MRNA icon

Toronto Dominion Bank’s Moderna MRNA Stock Holding History

Toronto Dominion Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-56,300
Closed -$2.34M – 1640
2024
Q4 		$2.34M Buy
+56,300
New +$2.69M ﹤0.01% 887

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Toronto Dominion Bank's MRNA Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Moderna (MRNA) stake by 20% in Q1 2026, selling an estimated $735K and leaving 62,012 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #999.

Toronto Dominion Bank first reported a position in MRNA in Q2 2020 and has held it in 24 quarters since. The position peaked at $120M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Toronto Dominion Bank held 62,012 shares of Moderna worth $3.15M as of Q1 2026.
  • Toronto Dominion Bank sold 15,760 Moderna shares in Q1 2026, an estimated $735K.
  • Moderna made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #999 holding.
  • Toronto Dominion Bank first reported a position in Moderna in Q2 2020 and has held it in 24 quarters since.
  • Toronto Dominion Bank's Moderna position peaked at $120M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.